Enigma Diagnostics appoints Dr. Lynn Busteed as Chief Executive Officer
Enigma diagnostics announced the appointment of Dr Lynn Busteed as Chief Executive Officer (CEO) and a member of the Board of Directors. This appointment completes Enigma Diagnostics' executive management team following the recent appointments of Biresh Roy as Chief Financial Officer and Mo Aslam as Programme Director.
Dr Busteed has more than 15 years experience in the life sciences sector, specialising in corporate and business development, strategic planning and operations. She joins Enigma from Focus Diagnostics, Inc., a US-based company providing products and services for the diagnosis of infectious diseases. At Focus Diagnostics, Dr Busteed was Vice President for Corporate Development with responsibility for a broad range of business development, licensing and M&A activities and a particular emphasis on acquisition of platforms and technology to fuel growth of the diagnostics products business.
From 2001 to 2004, Dr Busteed was Senior Director, Business Development and Strategic Planning at US company Celera Genomics Group (NYSE:CRA), a leader in the field of targeted medicine based on its genomics, proteomics and molecular diagnostics businesses.
Prior to this she spent seven years at management consulting firm McKinsey & Company in France and the UK where she gained broad experience in both strategic and operational consulting focusing on healthcare, chemicals and basic materials industries.
Topics
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.